Development, Execution and Acceptance of a Manualized Dance/Movement Therapy Treatment Protocol for the Clinical Trial in the Treatment of Negative Symptoms and Psychosocial Functioning in Schizophrenia

被引:0
|
作者
Karolina Bryl
Sherry Goodill
机构
[1] College of Nursing and Health Professions,Department of Creative Arts Therapies
[2] Drexel University,undefined
来源
American Journal of Dance Therapy | 2020年 / 42卷
关键词
Dance/movement therapy; Manualized treatment protocol; Intervention manual; Schizophrenia; Negative symptoms; Psychosocial functioning;
D O I
暂无
中图分类号
学科分类号
摘要
The use of manual-based interventions that aim to improve outcomes and that allow for replication become a research standard in recent years. Currently, the dance/movement therapy English language literature contains few if any works on specific guidelines or models to help researchers conceptualize, develop, pilot, revise and execute treatment protocols. Therefore, this manuscript describes in detail the development of manualized dance/movement therapy treatment protocol for a clinical trial on the negative symptoms and psychosocial functioning in individuals with schizophrenia. It provides a comprehensive description of the step-by-step process of the creation and implementation of the intervention manual. As such it offers a guideline to help researchers conceptualize, develop, pilot, revise and execute the treatment protocol. Feasibility and acceptance findings are included. Discussion of the importance of the use of manualized treatment protocols in dance/movement therapy research and their limitations follows.
引用
收藏
页码:150 / 175
页数:25
相关论文
共 50 条
  • [41] Severity of autism-related symptoms in treatment-resistant schizophrenia: associations with cognitive performance, psychosocial functioning, and neurological soft signs - Clinical evidence and ROC analysis
    Vellucci, Licia
    Barone, Annarita
    Buonaguro, Elisabetta Filomena
    Ciccarelli, Mariateresa
    De Simone, Giuseppe
    Iannotta, Federica
    Matrone, Marta
    Mazza, Benedetta
    Vitelli, Roberto
    de Bartolomeis, Andrea
    Iasevoli, Felice
    JOURNAL OF PSYCHIATRIC RESEARCH, 2025, 185 : 119 - 129
  • [42] Treatment of Negative Symptoms of Schizophrenia With tDCS (Transcranial Direct Current Stimulation): A Randomized, Sham-Controlled, Double-Blinded Clinical Trial
    Valiengo, Leandro
    van de Bilt, Martinus Theodorus
    Serpa, Mauricio
    Gordon, Pedro
    Helkis, Helio
    Gattaz, Wagner Farid
    Lacerda, Acioly
    Brunoni, Andre
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S207 - S207
  • [43] Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
    Liu, Fang
    Guo, Xiaofeng
    Wu, Rengrong
    Ou, Jianjun
    Zheng, Yingjun
    Zhang, Bingkui
    Xie, Liqin
    Zhang, Limei
    Yang, Li
    Yang, Shuyun
    Yang, Junwei
    Ruan, Ye
    Zeng, Yong
    Xu, Xiufeng
    Zhao, Jingping
    SCHIZOPHRENIA RESEARCH, 2014, 153 (1-3) : 169 - 176
  • [44] Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone
    Leucht, Stefan
    Dombi, Zsofia Borbala
    Szabo, Peter
    Barabassy, Agota
    Levine, Stephen Z.
    SCHIZOPHRENIA RESEARCH, 2023, 261 : 24 - 30
  • [45] Treatment of Schizophrenia With L-Tetrahydropalmatine (lTHP) for Positive and Negative Symptoms of Schizophrenia: Results of a 4-Week Double Blind Trial
    Kelly, Deanna
    Redman, Brianne
    Sayer, Maxie
    Wehring, Heidi J.
    Vyas, Gopal R.
    Richardson, Charles M.
    Gold, James
    Gorelick, David
    Cihakova, Daniela
    Hoag, Steven
    Buchanan, Robert
    Wang, Jingtao
    Chen, Shou
    Wang, Jia Bei
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 162 - 163
  • [46] Theta-burst rTMS in schizophrenia to ameliorate negative and cognitive symptoms: study protocol for a double-blind, sham-controlled, randomized clinical trial
    Csukly, Gabor
    Orban-Szigeti, Boglarka
    Suri, Karolin
    Zsigmond, Reka
    Herman, Levente
    Simon, Viktoria
    Kabaji, Anita
    Bata, Barnabas
    Harsfalvi, Peter
    Vass, Edit
    Csibri, Eva
    Farkas, Kinga
    Rethelyi, Janos
    TRIALS, 2024, 25 (01)
  • [47] Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study
    Berk, M
    Ichim, C
    Brook, S
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (02) : 87 - 92
  • [48] Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: Analysis of amisulpride vs placebo in three clinical trials
    Levine, Stephen Z.
    Leucht, Stefan
    SCHIZOPHRENIA RESEARCH, 2014, 156 (01) : 107 - 114
  • [49] RETRACTED: Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial (Retracted Article)
    Abdallah, Mahmoud S.
    Mosalam, Esraa M.
    Hassan, Ahmed
    Ramadan, Ahmed N.
    Omara-Reda, Hend
    Zidan, Abdel-Aziz A.
    Samman, Waad A.
    El-Berri, Eman, I
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (01) : 354 - 364
  • [50] The Selective Glycine Uptake Inhibitor Org 25935 as an Adjunctive Treatment to Atypical Antipsychotics in Predominant Persistent Negative Symptoms of Schizophrenia Results From the GIANT Trial
    Schoemaker, Joep H.
    Jansen, Wim T.
    Schipper, Jacques
    Szegedi, Armin
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (02) : 190 - 198